Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Wermuth

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Neurochemical Research|March 1, 1985
gamma-Hydroxybutyrate uptake by rat brain striatal slicesV Hechler, J J Bourguignon, C G Wermuth, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1987
SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodentsP Worms, J P Kan, C G Wermuth, et al.
Journal of Neurochemistry|June 1, 1987
Characterization of the binding of [3H]SR 95531, a GABAA antagonist, to rat brain membranesM Heaulme, J P Chambon, R Leyris, et al.
Neuropharmacology|November 1, 1986
Specific binding of a phenyl-pyridazinium derivative endowed with GABAA receptor antagonist activity to rat brainM Heaulme, J P Chambon, R Leyris, et al.
Journal of Medicinal Chemistry|December 1, 1987
Aryl diazo compounds and diazonium salts as potential irreversible probes of the gamma-aminobutyric acid receptorM J Bouchet, A Rendon, C G Wermuth, et al.
European Journal of Pharmacology|March 24, 1995
Novel arylaminopyridazine-GABA receptor antagonists examined electrophysiologically in Ascaris suumR J Martin, J M Sitamze, A H Duittoz, et al.
Journal of Medicinal Chemistry|August 10, 2001
Design, synthesis, and structure-activity relationships of a series of 3-[2-(1-benzylpiperidin-4-yl)ethylamino]pyridazine derivatives as acetylcholinesterase inhibitorsJ M Contreras, I Parrot, W Sippl, et al.
Journal of Computer-Aided Molecular Design|June 8, 2001
Structure-based 3D QSAR and design of novel acetylcholinesterase inhibitorsW Sippl, J M Contreras, I Parrot, et al.
Journal of Medicinal Chemistry|August 1, 1991
GABA-uptake inhibitors: construction of a general pharmacophore model and successful prediction of a new representativeV N'Goka, G Schlewer, J M Linget, et al.
Journal of Computer-Aided Molecular Design|July 1, 1997
Modelling of the binding site of the human m1 muscarinic receptor: experimental validation and refinementH Bourdon, S Trumpp-Kallmeyer, H Schreuder, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Neurochemical Research|March 1, 1985
gamma-Hydroxybutyrate uptake by rat brain striatal slicesV Hechler, J J Bourguignon, C G Wermuth, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1987
SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodentsP Worms, J P Kan, C G Wermuth, et al.
Journal of Neurochemistry|June 1, 1987
Characterization of the binding of [3H]SR 95531, a GABAA antagonist, to rat brain membranesM Heaulme, J P Chambon, R Leyris, et al.
Neuropharmacology|November 1, 1986
Specific binding of a phenyl-pyridazinium derivative endowed with GABAA receptor antagonist activity to rat brainM Heaulme, J P Chambon, R Leyris, et al.
Journal of Medicinal Chemistry|December 1, 1987
Aryl diazo compounds and diazonium salts as potential irreversible probes of the gamma-aminobutyric acid receptorM J Bouchet, A Rendon, C G Wermuth, et al.
European Journal of Pharmacology|March 24, 1995
Novel arylaminopyridazine-GABA receptor antagonists examined electrophysiologically in Ascaris suumR J Martin, J M Sitamze, A H Duittoz, et al.
Journal of Medicinal Chemistry|August 10, 2001
Design, synthesis, and structure-activity relationships of a series of 3-[2-(1-benzylpiperidin-4-yl)ethylamino]pyridazine derivatives as acetylcholinesterase inhibitorsJ M Contreras, I Parrot, W Sippl, et al.
Journal of Computer-Aided Molecular Design|June 8, 2001
Structure-based 3D QSAR and design of novel acetylcholinesterase inhibitorsW Sippl, J M Contreras, I Parrot, et al.
Journal of Medicinal Chemistry|August 1, 1991
GABA-uptake inhibitors: construction of a general pharmacophore model and successful prediction of a new representativeV N'Goka, G Schlewer, J M Linget, et al.
Journal of Computer-Aided Molecular Design|July 1, 1997
Modelling of the binding site of the human m1 muscarinic receptor: experimental validation and refinementH Bourdon, S Trumpp-Kallmeyer, H Schreuder, et al.
Pageof 5